OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
66 hedge funds and large institutions have $380M invested in Oyster Point Pharma, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Holders
66
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$2.69M | |
| 2 | +$2.23M | |
| 3 | +$1.43M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.38M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$1.14M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$6.5M | |
| 3 | -$3.05M | |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$1.89M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.56M |